| 
				 Toll 
				Brothers said that its orders, a key metric of future revenue 
				for homebuilders, rose 20.3 percent to 1,728 homes in the fourth 
				quarter ended Oct. 31. 
				 
				"We are encouraged as we look to FY 2017," Chief Executive 
				Douglas Yearley said in a statement. "We are seeing positive 
				demand trends in many regions." 
				 
				Toll Brothers said the average price of homes sold increased to 
				$834,300 in the quarter from $789,700 a year earlier, while the 
				number of homes sold rose to 2,224 from 1,820. 
				 
				The company, which has been building luxury homes for nearly 
				half a century, said it expects to deliver between 1,000 and 
				1,250 home at an average price of between $750,000 and $780,000 
				in the current quarter. 
				 
				Toll Brothers said its revenue rose 29.1 percent to $1.86 
				billion in the fourth quarter. 
				 
				Net income fell to $114.4 million, or 67 cents per share, from 
				$147.2 million, or 80 cents per share. 
				 
				Excluding $121.2 million in warranty charges mainly related to 
				older stucco homes and including some inventory writedowns, the 
				company earned $1.15 per share. 
				 
				On that basis, analysts on average were expecting a profit of 99 
				cents per share and revenue of $1.79 billion, according to 
				Thomson Reuters I/B/E/S. 
				 
				The company said it expects the purchase of Idaho-based Coleman 
				Real Estate Holdings Llc to hurt its 2017 adjusted gross margin 
				by 30-40 basis points. It bought Coleman Homes in November for 
				an undisclosed amount. 
				 
				Toll Brother's shares had fallen 8.5 percent this year through 
				Monday, slightly less than the Dow Jones U.S. home construction 
				index's <.DJUSHB> 8.8 percent decrease. 
				 
				(Reporting by Arunima Banerjee in Bengaluru; Editing by Savio 
				D'Souza) 
				
			[© 2016 Thomson Reuters. All rights 
				reserved.] Copyright 2016 Reuters. All rights reserved. This material may not be published, 
			broadcast, rewritten or redistributed. 
				   | 
				
				
				 |